内蒙古乌海地区幽门螺杆菌感染临床特征调查分析
Investigation and Analysis of Clinical Characteristics of Helicobacter pylori Infection in Wuhai of Inner Mongolia
DOI: 10.12677/acm.2025.153638, PDF,   
作者: 温 智, 陈 平*:内蒙古医科大学附属医院消化内科,内蒙古 呼和浩特;温 婷:北京市通州区漷县镇人民政府经济发展办公室(统计所),北京;杜永哲, 朱建斌:内蒙古乌海市人民医院消化内科,内蒙古 乌海
关键词: 幽门螺杆菌(H. pylori)感染率内蒙古乌海市慢性萎缩性胃炎消化性溃疡胃癌Helicobacter pylori (H. pylori) Infection Rate Wuhai Inner Mongolia Chronic Atrophic Gastritis Peptic Ulcer Gastric Cancer
摘要: 背景:幽门螺杆菌(Helicobacter pylori, H. pylori)是一种常见的胃黏膜感染性疾病,全球超过半数人口感染,与胃癌等多种胃部疾病有显著相关性。目的:本研究旨在分析内蒙古乌海地区幽门螺杆菌感染的临床特征及其与慢性胃炎、十二指肠球炎、消化性溃疡、胃癌的相关性。方法:研究选取了2023年1月至12月期间就诊于内蒙古乌海市人民医院门诊及体检中的896名患者,通过电子胃镜和碳13呼气试验进行检测,采用R × C列联表资料的χ2检验,对不同群体的幽门螺杆菌感染率进行分析。结果:本地区幽门螺杆菌感染率为45.4%,不同年龄段感染率存在显著性差异,青中年感染率高。感染者中,消化性溃疡、慢性萎缩性胃炎、胃癌的感染率分别为62.7%、58.3%、42.1%,均显著高于其他疾病。慢性萎缩性胃炎、消化性溃疡发展为胃癌的可能性较大。结论:内蒙古乌海地区青中年、慢性萎缩性胃炎、消化性溃疡、胃癌人群幽门螺杆菌感染风险高,应当进行幽门螺杆菌检测及治疗。研究结果为制定检测和治疗策略、预防胃癌发生提供参考。
Abstract: Background: Helicobacter pylori (H. pylori) is a common infectious disease of the gastric mucosa that infects more than half of the world’s population, and is positively correlated with a variety of gastric diseases, including gastric cancer. Objective: The aim of this study was to analyze the clinical characteristics of H. pylori infection and its correlation with chronic gastritis, duodenal bulb inflammation, peptic ulcer, and gastric cancer in western Inner Mongolia. Methods: Eight hundred and ninety-six patients who attended outpatient clinics and physical examinations at The People’s Hospital of Wuhai in Inner Mongolia between January and December 2023 were selected for the study and tested by gastroscopy examination and carbon 13 breath test. χ2 tests of R × C contingency tables were used to analyze the H. pylori infection rates among different groups. Results: The results showed that the infection rate of H. pylori in this region was 45.4%, with significant differences in the infection rate among different age groups, and a high infection rate among young and middle-aged people. The infection rates of peptic ulcer, chronic atrophic gastritis, and gastric cancer were 62.7%, 58.3%, and 42.1%, respectively, which were significantly higher than those of other diseases. Chronic atrophic gastritis and peptic ulcer were more likely to develop into gastric cancer. Conclusion: The risk of Helicobacter pylori infection is high among young and middle-aged, chronic atrophic gastritis, peptic ulcer, and gastric cancer populations in Wuhai of Inner Mongolia, who should be tested and treated for Helicobacter pylori. The results of the study provide a reference for the development of detection and treatment strategies and the prevention of gastric cancer.
文章引用:温智, 温婷, 杜永哲, 朱建斌, 陈平. 内蒙古乌海地区幽门螺杆菌感染临床特征调查分析[J]. 临床医学进展, 2025, 15(3): 466-476. https://doi.org/10.12677/acm.2025.153638

参考文献

[1] Warren, J.R. and Marshall, B. (1983) Unidentified Curved Bacilli on Gastric Epithelium in Active Chronic Gastritis. The Lancet, 321, 1273-1275.
[2] Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J.Y., Crowe, S.E., et al. (2015) Review Article: The Global Emergence of Helicobacter pylori Antibiotic Resistance. Alimentary Pharmacology & Therapeutics, 43, 514-533. [Google Scholar] [CrossRef] [PubMed]
[3] Helicobacter and Cancer Collaborative Group (2001) Gastric Cancer and Helicobacter pylori: A Combined Analysis of 12 Case Control Studies Nested within Prospective Cohorts. Gut, 49, 347-353. [Google Scholar] [CrossRef] [PubMed]
[4] Asaka, M., Sugiyama, T., Nobuta, A., Kato, M., Takeda, H. and Graham, D.Y. (2001) Atrophic Gastritis and Intestinal Metaplasia in Japan: Results of a Large Multicenter Study. Helicobacter, 6, 294-299. [Google Scholar] [CrossRef] [PubMed]
[5] Malfertheiner, P., Camargo, M.C., El-Omar, E., Liou, J., Peek, R., Schulz, C., et al. (2023) Helicobacter pylori Infection. Nature Reviews Disease Primers, 9, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
[6] Smyth, E.C., Nilsson, M., Grabsch, H.I., van Grieken, N.C. and Lordick, F. (2020) Gastric Cancer. The Lancet, 396, 635-648. [Google Scholar] [CrossRef] [PubMed]
[7] Hooi, J.K.Y., Lai, W.Y., Ng, W.K., Suen, M.M.Y., Underwood, F.E., Tanyingoh, D., et al. (2017) Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology, 153, 420-429. [Google Scholar] [CrossRef] [PubMed]
[8] Tytgat, G.N.J. (1991) The Sydney System: Endoscopic Division. Endoscopic Appearances in Gastritis/Duodenitis. Journal of Gastroenterology and Hepatology, 6, 223-234. [Google Scholar] [CrossRef] [PubMed]
[9] Marshall, B. and Warren, J.R. (1984) Unidentified Curved Bacilli in the Stomach of Patients with Gastritis and Peptic Ulceration. The Lancet, 323, 1311-1315. [Google Scholar] [CrossRef] [PubMed]
[10] Peek, R.M. and Blasser, MD, M.J. (1997) Pathophysiology of Helicobacter pylori-Induced Gastritis and Peptic Ulcer Disease. The American Journal of Medicine, 102, 200-207. [Google Scholar] [CrossRef] [PubMed]
[11] Correa, P. (1992) Human Gastric Carcinogenesis: A Multistep and Multifactorial Process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Research, 52, 6735-6740.
[12] De Falco, M., Lucariello, A., Iaquinto, S., Esposito, V., Guerra, G. and De Luca, A. (2015) Molecular Mechanisms of Helicobacter pylori Pathogenesis. Journal of Cellular Physiology, 230, 1702-1707. [Google Scholar] [CrossRef] [PubMed]
[13] Robinson, K. and Atherton, J.C. (2021) The Spectrum of Helicobacter-Mediated Diseases. Annual Review of Pathology: Mechanisms of Disease, 16, 123-144. [Google Scholar] [CrossRef] [PubMed]
[14] Fisher, L., Fisher, A. and Smith, P.N. (2020) Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). Journal of Clinical Medicine, 9, Article 3253. [Google Scholar] [CrossRef] [PubMed]
[15] Etchegaray-Morales, I., Jiménez-Herrera, E.A., Mendoza-Pinto, C., Rojas-Villarraga, A., Macías-Díaz, S., Osorio-Peña, Á.D., et al. (2021) Helicobacter pylori and Its Association with Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis and Sjögren Syndrome. Journal of Translational Autoimmunity, 4, Article 100135. [Google Scholar] [CrossRef] [PubMed]
[16] Wang, L., Cao, Z., Zhang, L., Dai, X., Liu, Z., Zeng, Y., et al. (2022) Helicobacter pylori and Autoimmune Diseases: Involving Multiple Systems. Frontiers in Immunology, 13, Article 833424. [Google Scholar] [CrossRef] [PubMed]
[17] Ren, S., Cai, P., Liu, Y., Wang, T., Zhang, Y., Li, Q., et al. (2021) Prevalence of Helicobacter pylori Infection in China: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology, 37, 464-470. [Google Scholar] [CrossRef] [PubMed]
[18] 苏小明, 祁海龙, 王小云, 等. 宁夏石嘴山地区590例志愿者幽门螺杆菌感染、耐药情况调查分析[J]. 山东医药, 2023, 63(17): 15-20.
[19] Porras, C., Nodora, J., Sexton, R., Ferreccio, C., Jimenez, S., Dominguez, R.L., et al. (2012) Epidemiology of Helicobacter pylori Infection in Six Latin American Countries (SWOG Trial S0701). Cancer Causes & Control, 24, 209-215. [Google Scholar] [CrossRef] [PubMed]
[20] Adlekha, S., Chadha, T., Krishnan, P. and Sumangala, B. (2013) Prevalence of Helicobacter pylori Infection among Patients Undergoing Upper Gastrointestinal Endoscopy in a Medical College Hospital in Kerala, India. Annals of Medical and Health Sciences Research, 3, 559-563.
[21] 张万岱, 胡伏莲, 萧树东, 等. 中国自然人群幽门螺杆菌感染的流行病学调查[J]. 现代消化及介入诊疗, 2010, 15(5): 265-270.
[22] Ying, J.J., Shu, X., Long, G. and Jiang, M. (2023) The Association between Helicobacter pylori Virulence Factor Genotypes and Gastroduodenal Diseases in Children. Chinese Journal of Pediatrics, 61, 827-832. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, X., Shu, X., Li, Q., Li, Y., Chen, Z., Wang, Y., et al. (2021) Prevalence and Risk Factors of Helicobacter pylori Infection in Wuwei, a High‐Risk Area for Gastric Cancer in Northwest China: An All‐Ages Population‐Based Cross‐sectional Study. Helicobacter, 26, e12810. [Google Scholar] [CrossRef] [PubMed]
[24] Canzian, F., Rizzato, C., Obazee, O., Stein, A., Flores‐Luna, L., Camorlinga‐Ponce, M., et al. (2020) Genetic Polymorphisms in the Cag Pathogenicity Island of Helicobacter pylori and Risk of Stomach Cancer and High‐Grade Premalignant Gastric Lesions. International Journal of Cancer, 147, 2437-2445. [Google Scholar] [CrossRef] [PubMed]
[25] Braunschweig, I., Nilius, I., Peitz, U., et al. (1998) Inhibits Secretory Leukocyte Protease Inhibitor-mRNA (SLPI) in Gastric Epithelial Cells Helicobacter pylori Infection? Gut, 43, A29.
[26] Pilotto, A. and Malfertheiner, P. (2002) An Approach to Helicobacter pylori Infection in the Elderly. Alimentary Pharmacology & Therapeutics, 16, 683-691. [Google Scholar] [CrossRef] [PubMed]
[27] 田宏扬, 严华芳, 乔春萍, 等. 上海市浦东新区南部体检人群幽门螺杆菌感染情况及相关因素分析[J]. 复旦学报(医学版), 2022, 49(5): 720-725, 732.
[28] Malfertheiner, P., Megraud, F., O’Morain, C.A., Gisbert, J.P., Kuipers, E.J., Axon, A.T., et al. (2016) Management of Helicobacter pylori Infection—The Maastricht V/Florence Consensus Report. Gut, 66, 6-30. [Google Scholar] [CrossRef] [PubMed]
[29] Liou, J.M., Liou, J.M., Liou, J.M., et al. (2020) Screening and Eradication of Helicobacter pylori for Gastric Cancer Prevention: The Taipei Global Consensus. Gut, 69, 2093-2112. [Google Scholar] [CrossRef] [PubMed]
[30] 王江滨. 老年幽门螺杆菌感染者根除治疗的获益/风险评价及抗生素应用相关问题[J]. 中华医学杂志, 2020, 100(30): 2343-2345.
[31] Lee, Y., Chen, T.H., Chiu, H., Shun, C., Chiang, H., Liu, T., et al. (2012) The Benefit of Mass Eradication of Helicobacter pylori Infection: A Community-Based Study of Gastric Cancer Prevention. Gut, 62, 676-682. [Google Scholar] [CrossRef] [PubMed]
[32] Ford, A.C., Gurusamy, K.S., Delaney, B., Forman, D. and Moayyedi, P. (2016) Eradication Therapy for Peptic Ulcer Disease in Helicobacter pylori-Positive People. Cochrane Database of Systematic Reviews, No. 4, CD003840. [Google Scholar] [CrossRef] [PubMed]
[33] Huang, J., Sridhar, S. and Hunt, R.H. (2002) Role of Helicobacter pylori Infection and Non-Steroidal Anti-Inflammatory Drugs in Peptic-Ulcer Disease: A Meta-Analysis. The Lancet, 359, 14-22. [Google Scholar] [CrossRef] [PubMed]
[34] El-Serag, H.B., Kao, J.Y., Kanwal, F., Gilger, M., LoVecchio, F., Moss, S.F., et al. (2018) Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clinical Gastroenterology and Hepatology, 16, 992-1002.E6. [Google Scholar] [CrossRef] [PubMed]
[35] Fernández Salazar, L. and Valle Muñoz, J. (2022) 2021 Guidelines on Helicobacter pylori. Coincidences and Divergences between the Spanish and World Gastroenterology Organisation (WGO) Guidelines. Revista Española de Enfermedades Digestivas, 114, 129-132. [Google Scholar] [CrossRef] [PubMed]
[36] 中华医学会消化病学分会幽门螺杆菌学组. 第六次全国幽门螺杆菌感染处理共识报告(非根除治疗部分) [J]. 胃肠病学, 2022, 27(5): 289-304.
[37] Hernández-Díaz, S. and García Rodríguez, L.A. (2006) Cardioprotective Aspirin Users and Their Excess Risk of Upper Gastrointestinal Complications. BMC Medicine, 4, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[38] The EUROGAST Study Group (1993) Epidemiology of, and Risk Factors for, Helicobacter pylori Infection among 3194 Asymptomatic Subjects in 17 Populations. Gut, 34, 1672-1676. [Google Scholar] [CrossRef] [PubMed]
[39] Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[40] Shin, C.M., Kim, N., Yang, H.J., Cho, S., Lee, H.S., Kim, J.S., et al. (2010) Stomach Cancer Risk in Gastric Cancer Relatives: Interaction between Helicobacter pylori Infection and Family History of Gastric Cancer for the Risk of Stomach Cancer. Journal of Clinical Gastroenterology, 44, e34-e39. [Google Scholar] [CrossRef] [PubMed]
[41] Zhang, D.H., Zhou, L.Y., Lin, S.R., et al. (2009) Recent Changes in the Prevalence of Helicobacter pylori Infection among Children and Adults in High-or Low-Incidence Regions of Gastric Cancer in China. Chinese Medical Journal, 122, 1759-1763.
[42] Wroblewski, L.E. and Peek, R.M. (2016) Helicobacter pylori, Cancer, and the Gastric Microbiota. In: Jansen, M. and Wright, N., Eds., Stem Cells, Pre-Neoplasia, and Early Cancer of the Upper Gastrointestinal Tract, Springer International Publishing, 393-408. [Google Scholar] [CrossRef] [PubMed]
[43] Siavoshi, F., Heydari, S., Shafiee, M., Ahmadi, S., Saniee, P., Sarrafnejad, A., et al. (2019) Sequestration Inside the Yeast Vacuole May Enhance Helicobacter pylori Survival against Stressful Condition. Infection, Genetics and Evolution, 69, 127-133. [Google Scholar] [CrossRef] [PubMed]
[44] de Vries, A.C., van Grieken, N.C.T., Looman, C.W.N., Casparie, M.K., de Vries, E., Meijer, G.A., et al. (2008) Gastric Cancer Risk in Patients with Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands. Gastroenterology, 134, 945-952. [Google Scholar] [CrossRef] [PubMed]
[45] O’Connor, A., O’Morain, C.A. and Ford, A.C. (2017) Population Screening and Treatment of Helicobacter pylori Infection. Nature Reviews Gastroenterology & Hepatology, 14, 230-240. [Google Scholar] [CrossRef] [PubMed]
[46] Piazuelo, M.B., Bravo, L.E., Mera, R.M., Camargo, M.C., Bravo, J.C., Delgado, A.G., et al. (2021) The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients with Gastric Precancerous Lesions. Gastroenterology, 160, 1106-1117.E3. [Google Scholar] [CrossRef] [PubMed]
[47] Wu, Y., Su, T., Zhou, X., Lu, N., Li, Z. and Du, Y. (2020) Awareness and Attitudes Regarding Helicobacter pylori Infection in Chinese Physicians and Public Population: A National Cross‐Sectional Survey. Helicobacter, 25, e12705. [Google Scholar] [CrossRef] [PubMed]